HOME >> MEDICINE >> NEWS
Automated external defibrillators are frequently recalled

BOSTON A new study shows that automated external defibrillators (AEDs), the devices used to resuscitate victims of sudden cardiac arrest, had a greater than 20 percent chance of being recalled for potential malfunction over the past decade.

The findings, reported in the August 9 issue of The Journal of the American Medical Association (JAMA), suggest the need for a more reliable system to locate and repair potentially defective devices in a timely fashion.

"Though they are simple to use, AEDs are, in fact, complex medical devices," explains the study's senior author William Maisel, MD, MPH, director of the Pacemaker and Defibrillator Service at Beth Israel Deaconess Medical Center (BIDMC) and Assistant Professor of Medicine at Harvard Medical School. "It is therefore not surprising that they may occasionally malfunction. An AED recall rate of 1 in 5 over the past decade, however, is too high."

The portable units provide voice commands, automated heart rhythm analysis, and if necessary, shock delivery to resuscitate victims of cardiac arrest. Their ease of operation -- coupled with their clinically proven ability to improve the survival of cardiac arrest victims -- has resulted in their widespread use in recent years.

"During the period we followed between 1996 and 2005 the annual number of AEDs distributed increased almost 10-fold, from fewer than 20,000 in 1996 to nearly 200,000 in 2005," says Maisel. Many public areas such as airports, sports arenas, casinos, schools and churches are now routinely outfitted with AEDs, and certain AED models have even been approved by the U.S. Food and Drug Administration (FDA) for use without a prescription, enabling consumers to purchase them more easily.

In their study, Maisel and coauthor Jignesh Shah, MD, of BIDMC's Cardiovascular Division determined the number and rate of AED safety alerts and recalls (collectively referred to as "advisories") as well as the number of
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
8-Aug-2006


Page: 1 2

Related medicine news :

1. FDA safety alerts for automated external defibrillators occur frequently
2. New data finds recalls of automated external defibrillators to be common
3. Enhanced external counterpulsation reduces angina, says University of Pittsburgh study
4. CPR and external defibrillator training may decrease adolescent sports-related deaths
5. MRIs made safe for people with modern defibrillators and pacemakers
6. Clinical guidelines for recalled pacemakers and implantable cardioverter-defibrillators developed
7. Implantable defibrillators save lives but may increase heart failure risk
8. Best settings for biphasic automated defibrillators investigated
9. Implantable cardioverter-defibrillators have higher malfunction rate than pacemakers
10. Study finds implantable defibrillators as effective in women as in men
11. Large-scale study proves volunteer operated defibrillators are life-savers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Automated external defibrillators are frequently recalled

(Date:5/20/2013)... May 20, 2013 yurbuds®, maker of ... out, today announced the launch of its new Signature ... Series-Pete Jacobs, with more signature athletes to come. Created ... Signature Series ITE 100 is the perfect training partner ... ITE 100 features reflective, tangle-resistant Kevlar cords, premium sound ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal ... female lawyers to be included in a plaintiffs’ leadership ... acknowledges the judge’s request, noting that its lawyers ... on Mirena side effects and how to file a ... of some female lawyers to the committee. This followed ...
(Date:5/20/2013)... WINSTON-SALEM, N.C. May 20, 2013 Nearly 20 ... in the U.S. are refused for transplant due to ... the kidney,s filtering units to the organ going too ... of being discarded, these organs could be "recycled" to ... Researchers at Wake Forest Baptist Medical Center and colleagues, ...
(Date:5/20/2013)... Amsterdam, NL, 20 May 2013 While Huntington,s ... community anticipates that new disease-modifying therapies in development ... success of HD research depends upon the identification ... and evaluate therapies, and these biomarkers may eventually ... Biomarkers could be especially helpful to monitor changes ...
(Date:5/20/2013)... Dorland Health, a division of ... annual Case In Point Platinum Awards, recognizing outstanding ... the system is patient- and family-centric, safe and ... creative work across the healthcare system that is ... of care through effective care coordination across the ...
Breaking Medicine News(10 mins):Health News:yurbuds Expands Best-Selling Lines with Innovative New Products 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Study suggests new source of kidneys for transplant 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2
(Date:5/20/2013)... , May 20, 2013 Sequent Medical, ... for the SL ("Single Layer") family of WEB ® ... release of these new models in select neurovascular centers ... and superior navigability that will enable physicians to treat ... The SL configurations are made possible by ...
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... 20, 2013 Enrollment of patients with Type ... dose-finding clinical trial of product candidate NewMet ™, ... for Type 2 diabetes. Elcelyx expects to complete enrollment ... June. Results of the trial,s primary endpoint of change ... and the read-out for long-term glucose lowering and weight ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4
Cached News: